Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults

By Di Tommaso A.   Bartalini M.   Peppoloni S.   Podda A.   Rappuoli R.   De Magistris M.T.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1218-1224

Elsevier

Access to resources Recommend Favorite

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens

By van den Berg B.M.   David S.   Beekhuizen H.   Mooi F.R.   van Furth R.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1118-1128

Elsevier

Access to resources Recommend Favorite

Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age

By Li-Min H.   Chin-Yun L.   Tzou-Yien L.   Jong-Min C.   Ping-Ing L.   Ching-Ying H.  

Vaccine, Vol. 14, Iss. 9, 1996-06 ,pp. : 916-922

Elsevier

Access to resources Recommend Favorite

Immunogenicity of hepatitis B vaccines among infant recipients of acellular and whole cell pertussis DTP vaccines

By Salmaso S.   Piscitelli A.   Rapicetta M.   Chionne P.   Madonna E.   Argentini C.  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 643-646

Elsevier

Access to resources Recommend Favorite

Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults

By Tran Minh N.N.   He Q.   Edelman K.   Putto-Laurila A.   Arvilommi H.   Viljanen M.K.   Mertsola J.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 1971-1974

Elsevier

Access to resources Recommend Favorite